OnKure Therapeutics (OKUR) Earnings Date, Estimates & Call Transcripts $2.73 -0.01 (-0.36%) Closing price 04:00 PM EasternExtended Trading$2.73 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock OnKure Therapeutics Earnings Summary OnKure Therapeutics issued Q2 2025 earnings on August 12, 2025, reporting an EPS of -$1.14, which beat the consensus estimate of -$1.23 by $0.09. With a trailing EPS of -$4.80, OnKure Therapeutics' earnings are expected to grow next year, from ($4.05) to ($3.41) per share. Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportOKUR Upcoming EarningsOnKure Therapeutics' next earnings date is estimated for Thursday, November 6, 2025, based on past reporting schedules. Upcoming Q3 Earnings DateNov. 6Before Market OpensEstimatedConsensus EPS (Aug. 12) -$1.23 Actual EPS (Aug. 12) -$1.14 Beat By $0.09 Get OnKure Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OnKure Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataOKUR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. OnKure Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.41-$1.22-$1.32Q2 20252-$1.43-$1.21-$1.32Q3 20252-$1.27-$1.17-$1.22Q4 20252-$1.15-$1.09-$1.12 OnKure Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/6/2025(Estimated)--------8/12/2025Q2 2025-$1.23-$1.14+$0.09-$1.14--5/6/2025Q1 2025-$1.41-$1.19+$0.22-$1.19--3/10/2025Q4 2024-$0.86-$1.37 -$0.51-$1.37--11/7/2024Q3 2024-$0.97-$1.10 -$0.13-$1.10--8/13/2024Q2 2024-$1.70-$1.60+$0.10-$1.60--5/7/2024Q1 2024-$3.70-$2.50+$1.20-$2.50--3/28/2024Q4 2023-$5.50-$7.00 -$1.50-$7.00--11/13/2023Q3 2023-$6.00-$5.70+$0.30-$5.70-- OnKure Therapeutics Earnings - Frequently Asked Questions When is OnKure Therapeutics' earnings date? OnKure Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based off last year's report dates. Learn more on OKUR's earnings history. Did OnKure Therapeutics beat their earnings estimates last quarter? In the previous quarter, OnKure Therapeutics (NASDAQ:OKUR) reported ($1.14) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.23) by $0.09. Learn more on analysts' earnings estimate vs. OKUR's actual earnings. How much profit does OnKure Therapeutics generate each year? OnKure Therapeutics (NASDAQ:OKUR) has a recorded net income of -$52.67 million. OKUR has generated -$4.80 earnings per share over the last four quarters. What is OnKure Therapeutics' EPS forecast for next year? OnKure Therapeutics' earnings are expected to grow from ($4.05) per share to ($3.41) per share in the next year. More Earnings Resources from MarketBeat Related Companies IMRX Earnings GNLX Earnings HURA Earnings CTOR Earnings CLYM Earnings ACOG Earnings CGEN Earnings SCLX Earnings FATE Earnings PLX Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles DLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals? This page (NASDAQ:OKUR) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OnKure Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OnKure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access